Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.
In 1995, Pharmacia & Upjohn was formed through the merger of Pharmacia AB and The Upjohn Company. Pharmacia & Upjohn became a global provider of human health care products, animal health products, diagnostics and specialty products. In 1998, Pharmacia & Upjohn relocated its global headquarters from the ...
Pharmaceutical company profile for Pharmacia & Upjohn Company LLC.
Pharmacia & Upjohn LLC develops, manufactures, and sells pharmaceutical and healthcare products. The company conducts its business through the prescription pharmaceutical and consumer healthcare segments, and various other smaller operating units. The prescription pharmaceutical segment includes general ...
It also manufactures pharmaceutical chemicals for use in its own products and for bulk sales. It was formerly known as The Upjohn Company, Inc. and changed its name to Pharmacia & Upjohn Company LLC in 1995. The company was founded in 1886 and is based in Kalamazoo, Michigan. Pharmacia & Upjohn Company ...
Oct 19, 2009 ... PHARMACIA & UPJOHN COMPANY, INC., a subsidiary of Pfizer Inc. ("Pfizer") today was sentenced today in federal court for a felony violation of the Food, Drug & Cosmetic Act, for misbranding the drug, Bextra, with the intent to defraud or mislead.
Jul 30, 2012 ... Pharmacia & Upjohn Company LLC (a subsidiary of Pfizer Inc.) requests a new NRC byproduct material license for its manufacturing facility located at 7000 Portage Road,. Kalamazoo, Michigan. This facility is presently authorized to use radioactive materials under NRC byproduct material license number ...
Read about the corporate relationships among Monsanto Company, Pharmacia LLC, Pfizer Inc., Solutia Inc., and Eastman Chemical Company. ... Dec. 19, 1999. Pharmacia (then known as Monsanto Company) entered into an agreement with Pharmacia & Upjohn, Inc. (PNU) relating to a merger (the Merger).
Apr 16, 2003 ... Pfizer stock fell 53 cents to $31.68 Wednesday afternoon. Efficiencies from the deal, Pfizer said, will save $2.5 billion in 2005. The closing of the deal brings an end to Pharmacia, which started as a Sweden-based company and merged with U.S. drugmaker Upjohn in 1995 to become Pharmacia & Upjohn.